These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE). Morimoto C Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583 [TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus. Scheinberg MA; Cathcart ES Clin Exp Immunol; 1976 May; 24(2):317-22. PubMed ID: 1084243 [TBL] [Abstract][Full Text] [Related]
5. A serum inhibitor of immune regulation in patients with systemic lupus erythematosus. Twomey JJ; Laughter AH; Steinberg AD J Clin Invest; 1978 Sep; 62(3):713-5. PubMed ID: 308514 [TBL] [Abstract][Full Text] [Related]
6. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells. Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769 [TBL] [Abstract][Full Text] [Related]
7. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction. Sagawa A; Abdou NI J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787 [TBL] [Abstract][Full Text] [Related]
8. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction. Sagawa A; Abdou NI J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952 [TBL] [Abstract][Full Text] [Related]
9. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163 [TBL] [Abstract][Full Text] [Related]
10. [The dysfunction of human peripheral blood dendritic cells on concanavalin A-induced T cell responses in patients with systemic lupus erythematosus]. Katagiri T Arerugi; 1992 Jun; 41(6):693-8. PubMed ID: 1444821 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity. Robak E; Niewiadomska H; Robak T; Bartkowiak J; Błoński JZ; Woźniacka A; Pomorski L; Sysa-Jedrezejowska A Mediators Inflamm; 2001 Aug; 10(4):179-89. PubMed ID: 11577994 [TBL] [Abstract][Full Text] [Related]
12. Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus. Alcocer-Varela J; Laffon A; Alarcón-Segovia D Clin Exp Immunol; 1984 Jan; 55(1):125-32. PubMed ID: 6229371 [TBL] [Abstract][Full Text] [Related]
13. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus. Martinez-Cordero E; Alcocer-Varela J; Alarcon-Segovia D Clin Exp Immunol; 1986 Sep; 65(3):598-604. PubMed ID: 3490941 [TBL] [Abstract][Full Text] [Related]
14. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics. Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730 [TBL] [Abstract][Full Text] [Related]
16. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. Sakane T; Steinberg AD; Reeves JP; Green I J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810 [TBL] [Abstract][Full Text] [Related]
17. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population. Pozsonyi T; Jakab L; Fehér J Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515 [TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus]. Yang JH; Shen Q; Zhao DB; Cai Q; Han XH Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508 [TBL] [Abstract][Full Text] [Related]
19. Suppressor T cell dysfunction and depressed immunoglobulin production by B cells in vitro in patients with SLE. Nishinarita S; Takizawa I; Hirai H; Morita K; Amaki I J Rheumatol; 1981; 8(1):19-30. PubMed ID: 6452522 [TBL] [Abstract][Full Text] [Related]
20. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. Devi BS; Van Noordin S; Krausz T; Davies KA J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]